Midlife Women’s Health 2023 provides a multi-disciplinary approach to the care of menopausal women. Advances in research, technology, and pharmacology increase options available for midlife women, but this rapidly changing knowledge-base presents a challenge for clinicians. Care for women at this stage of life is optimized by education on a range of medical concerns provided by experts from a wide variety of medical specialties. Given demographic changes in the US population, midlife women are becoming an increasingly important group served by health care professionals, with needs that cross many areas of medical expertise.

In this educational activity, a multidisciplinary group of experts from Massachusetts General Hospital will present on the evaluation and management of mood disorders, cancer survivorship, skin health, recurrent UTIs, obesity, cardiovascular health, transgender medicine, early menopause, menopausal hormone therapy, and novel non-hormonal options for hot flashes to assist clinicians in caring for their midlife patients.

Target Audience

This educational activity is intended for physicians and advance practice nurses in primary care, gynecology, general surgery, internal medicine, endocrinology, psychiatry, gynecological oncology, cardiology, and preventive medicine who provide care to midlife women. Physicians and advance practice nurses in-training also are encouraged to attend.

Learning Objectives

Upon completion of this activity, participants will be able to:

1. Formulate a strategy to optimize care of cancer survivors after menopause
2. Employ a greater understanding of transgender health to optimize midlife care
3. Evaluate and treat recurrent urinary tract infections in aging women
4. Integrate digital innovation to improve cardiovascular health outcomes in midlife women
5. Recognize midlife mood disorders and optimize care
6. Utilize behavioral and pharmacologic strategies to manage obesity at midlife
7. Integrate education and strategies to optimize the perimenopausal transition
8. Assess a midlife woman’s risk of skin aging and guide her in utilizing available treatment options
9. Utilize NK3-receptor antagonists as a novel and effective treatment for hot flashes once available
10. Evaluate symptomatic midlife women for menopausal hormone therapy, incorporating an individualized assessment of risks and benefits

Program : 

Friday, May 12, 2023

7:45 a.m. - Welcome & Introductory Remarks

Jan Shifren, MD, NCMP

8:00 a.m. - Cancer Survivorship & Lifestyle Medicine

Amy Comander, MD

8:45 a.m. - Transgender Medicine at Midlife

Jenny Siegel, MD

9:30 a.m. - Recurrent UTIs in Aging Women: Evaluation & Management

May Wakamatsu, MD
Jacob Lazarus, MD, PhD

10:15 a.m. - BREAK

10:30 a.m. - Digital Innovation for Improving Cardiovascular Health Outcomes in Midlife Women

Kaavya Paruchuri, MD

11:15 a.m. - Managing Midlife Mood Mayhem

Marlene Freeman, MD

12:00 p.m. - LUNCH BREAK

1:00 p.m. - Pharmacologic Treatment Options of Obesity

Klara Rosenquist, MD

1:45 p.m. - Early Menopause: Strategies to Reduce Risk

Carey York-Best, MD

2:30 p.m. - Keeping Skin Healthy as the Clock Ticks

Sandy Tsao, MD

3:15 p.m. - BREAK

3:30 p.m. - Keynote Presentation: NK3-R Antagonists: Novel & Effective Treatment for Hot Flashes

Susan Reed, MD, MPH

4:15 p.m. - Everything You Wanted to Know About Hormone Therapy, But Were Afraid to Ask